Quanterix names Yuri Fesko as chief medical officer
Reuters2026/09/14 12:02- Quanterix appointed Dr. Yuri Fesko as chief medical officer to lead medical and clinical strategy across diagnostics, R&D, regulatory, scientific, commercial teams.
- Fesko previously served as chief medical officer at Quest Diagnostics, overseeing medical affairs, clinical development, analytics, public health, quality support.
- Appointment comes as Quanterix prepares a broader launch of its Lucent AD Complete Alzheimer’s test, with work continuing on an IVD filing.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
How will the 110 trillion KRW AI dividend be distributed? Seoul-based hedge fund pressures Samsung to immediately buy back and cancel preferred shares
A South Korean hedge fund is pressuring Samsung to buy back and cancel its preferred shares, planning to use 73 trillion won of a 110 trillion won return plan for the repurchase, aiming to eliminate a discount of over 25%.

Extreme level of 8,500 emerges! Two top strategists raise S&P 500 target as strong earnings become key support
Despite facing a surge in US Treasury yields surpassing 5% and a slowdown in the AI sector, Wall Street institutions continue to raise their S&P 500 target prices, with the most bullish forecasts reaching up to 8,500 points.

BIG Impact invests in autoimmune diagnostics and drug discovery startup AOI Biosciences
LG Electronics Gains a Bull on Likely 3Q Earnings Beat -- Market Talk